MANILA, Philippines — Ayala Corporation’s healthcare arm, AC Health, has secured a strategic investment from a private equity firm backed by Singapore’s state investor Temasek Holdings, acquiring a 16% minority stake in the rapidly growing business.
While the financial terms of the deal were not disclosed, previous estimates have valued AC Health at up to $500 million, underscoring the unit’s strong growth potential and attractiveness to regional investors.
Founded in 2015, AC Health has quickly built a comprehensive healthcare network in the Philippines. Its portfolio includes well-known pharmacy chains Generika and St. Joseph Drug, as well as clinics, hospitals, and digital health platforms. The company has set ambitious expansion goals, aiming to operate at least 10 hospitals, 300 clinics, and 1,150 pharmacies in the coming years.
The investment marks another significant milestone in AC Health’s growth trajectory, giving it both capital and strategic backing to accelerate expansion in a sector seen as vital to the Philippines’ development.
Ayala Corporation, one of the country’s largest and oldest conglomerates, has steadily diversified into healthcare to complement its established businesses in real estate, banking, telecommunications, and utilities.
The Temasek-linked entry highlights continued investor confidence in the Philippine healthcare market, especially as demand for quality medical services and accessible treatment continues to rise across the archipelago.
— With reports from Reuters
Post a Comment